1 00:00:00,723 --> 00:00:02,899 So let me ask for a show of hands. 2 00:00:02,899 --> 00:00:07,091 How many people here are over the age of 48? 3 00:00:07,091 --> 00:00:09,972 Well, there do seem to be a few. 4 00:00:09,972 --> 00:00:12,147 Well, congratulations, 5 00:00:12,147 --> 00:00:16,017 because if you look at this particular slide of U.S. life expectancy, 6 00:00:16,017 --> 00:00:19,115 you are now in excess of the average life span 7 00:00:19,115 --> 00:00:21,902 of somebody who was born in 1900. 8 00:00:21,902 --> 00:00:25,436 But look what happened in the course of that century. 9 00:00:25,436 --> 00:00:27,098 If you follow that curve, 10 00:00:27,098 --> 00:00:29,712 you'll see that it starts way down there. 11 00:00:29,712 --> 00:00:32,181 There's that dip there for the 1918 flu. 12 00:00:32,181 --> 00:00:34,603 And here we are at 2010, 13 00:00:34,603 --> 00:00:37,659 average life expectancy of a child born today, age 79, 14 00:00:37,659 --> 00:00:39,555 and we are not done yet. 15 00:00:39,555 --> 00:00:40,890 Now, that's the good news. 16 00:00:40,890 --> 00:00:42,731 But there's still a lot of work to do. 17 00:00:42,731 --> 00:00:44,365 So, for instance, if you ask, 18 00:00:44,365 --> 00:00:47,091 how many diseases do we now know 19 00:00:47,091 --> 00:00:49,150 the exact molecular basis? 20 00:00:49,150 --> 00:00:52,708 Turns out it's about 4,000, which is pretty amazing, 21 00:00:52,708 --> 00:00:54,944 because most of those molecular discoveries 22 00:00:54,944 --> 00:00:57,609 have just happened in the last little while. 23 00:00:57,609 --> 00:01:00,905 It's exciting to see that in terms of what we've learned, 24 00:01:00,905 --> 00:01:03,012 but how many of those 4,000 diseases 25 00:01:03,012 --> 00:01:05,360 now have treatments available? 26 00:01:05,360 --> 00:01:07,248 Only about 250. 27 00:01:07,248 --> 00:01:10,006 So we have this huge challenge, this huge gap. 28 00:01:10,006 --> 00:01:12,586 You would think this wouldn't be too hard, 29 00:01:12,586 --> 00:01:14,112 that we would simply have the ability 30 00:01:14,112 --> 00:01:17,138 to take this fundamental information that we're learning 31 00:01:17,138 --> 00:01:20,283 about how it is that basic biology teaches us 32 00:01:20,283 --> 00:01:22,185 about the causes of disease 33 00:01:22,185 --> 00:01:25,211 and build a bridge across this yawning gap 34 00:01:25,211 --> 00:01:27,591 between what we've learned about basic science 35 00:01:27,591 --> 00:01:29,086 and its application, 36 00:01:29,086 --> 00:01:32,343 a bridge that would look maybe something like this, 37 00:01:32,343 --> 00:01:35,955 where you'd have to put together a nice shiny way 38 00:01:35,955 --> 00:01:38,923 to get from one side to the other. 39 00:01:38,923 --> 00:01:41,523 Well, wouldn't it be nice if it was that easy? 40 00:01:41,523 --> 00:01:43,668 Unfortunately, it's not. 41 00:01:43,668 --> 00:01:46,259 In reality, trying to go from fundamental knowledge 42 00:01:46,259 --> 00:01:48,923 to its application is more like this. 43 00:01:48,923 --> 00:01:50,838 There are no shiny bridges. 44 00:01:50,838 --> 00:01:52,490 You sort of place your bets. 45 00:01:52,490 --> 00:01:54,451 Maybe you've got a swimmer and a rowboat 46 00:01:54,451 --> 00:01:55,975 and a sailboat and a tugboat 47 00:01:55,975 --> 00:01:57,703 and you set them off on their way, 48 00:01:57,703 --> 00:02:00,367 and the rains come and the lightning flashes, 49 00:02:00,367 --> 00:02:01,881 and oh my gosh, there are sharks in the water 50 00:02:01,881 --> 00:02:03,902 and the swimmer gets into trouble, 51 00:02:03,902 --> 00:02:05,486 and, uh oh, the swimmer drowned 52 00:02:05,486 --> 00:02:08,698 and the sailboat capsized, 53 00:02:08,698 --> 00:02:10,399 and that tugboat, well, it hit the rocks, 54 00:02:10,399 --> 00:02:13,039 and maybe if you're lucky, somebody gets across. 55 00:02:13,039 --> 00:02:15,028 Well, what does this really look like? 56 00:02:15,028 --> 00:02:17,082 Well, what is it to make a therapeutic, anyway? 57 00:02:17,082 --> 00:02:20,083 What's a drug? A drug is made up 58 00:02:20,083 --> 00:02:22,408 of a small molecule of hydrogen, carbon, 59 00:02:22,408 --> 00:02:24,659 oxygen, nitrogen, and a few other atoms 60 00:02:24,659 --> 00:02:26,882 all cobbled together in a shape, 61 00:02:26,882 --> 00:02:29,259 and it's those shapes that determine whether, in fact, 62 00:02:29,259 --> 00:02:32,572 that particular drug is going to hit its target. 63 00:02:32,572 --> 00:02:34,795 Is it going to land where it's supposed to? 64 00:02:34,795 --> 00:02:37,951 So look at this picture here -- a lot of shapes dancing around for you. 65 00:02:37,951 --> 00:02:40,338 Now what you need to do, if you're trying to develop 66 00:02:40,338 --> 00:02:41,795 a new treatment for autism 67 00:02:41,795 --> 00:02:44,014 or Alzheimer's disease or cancer 68 00:02:44,014 --> 00:02:45,806 is to find the right shape in that mix 69 00:02:45,806 --> 00:02:48,723 that will ultimately provide benefit and will be safe. 70 00:02:48,723 --> 00:02:51,890 And when you look at what happens to that pipeline, 71 00:02:51,890 --> 00:02:53,391 you start out maybe with thousands, 72 00:02:53,391 --> 00:02:55,033 tens of thousands of compounds. 73 00:02:55,033 --> 00:02:57,182 You weed down through various steps 74 00:02:57,182 --> 00:02:58,565 that cause many of these to fail. 75 00:02:58,565 --> 00:03:01,905 Ultimately, maybe you can run a clinical trial with four or five of these, 76 00:03:01,905 --> 00:03:04,947 and if all goes well, 14 years after you started, 77 00:03:04,947 --> 00:03:06,958 you will get one approval. 78 00:03:06,958 --> 00:03:08,988 And it will cost you upwards of a billion dollars 79 00:03:08,988 --> 00:03:11,132 for that one success. 80 00:03:11,132 --> 00:03:14,436 So we have to look at this pipeline the way an engineer would, 81 00:03:14,436 --> 00:03:15,644 and say, "How can we do better?" 82 00:03:15,644 --> 00:03:18,321 And that's the main theme of what I want to say to you this morning. 83 00:03:18,321 --> 00:03:20,134 How can we make this go faster? 84 00:03:20,134 --> 00:03:23,199 How can we make it more successful? 85 00:03:23,199 --> 00:03:24,540 Well, let me tell you about a few examples 86 00:03:24,540 --> 00:03:26,796 where this has actually worked. 87 00:03:26,796 --> 00:03:29,747 One that has just happened in the last few months 88 00:03:29,747 --> 00:03:33,457 is the successful approval of a drug for cystic fibrosis. 89 00:03:33,457 --> 00:03:35,111 But it's taken a long time to get there. 90 00:03:35,111 --> 00:03:39,713 Cystic fibrosis had its molecular cause discovered in 1989 91 00:03:39,713 --> 00:03:42,041 by my group working with another group in Toronto, 92 00:03:42,041 --> 00:03:44,176 discovering what the mutation was in a particular gene 93 00:03:44,176 --> 00:03:45,804 on chromosome 7. 94 00:03:45,804 --> 00:03:47,842 That picture you see there? 95 00:03:47,842 --> 00:03:49,945 Here it is. That's the same kid. 96 00:03:49,945 --> 00:03:53,289 That's Danny Bessette, 23 years later, 97 00:03:53,289 --> 00:03:54,568 because this is the year, 98 00:03:54,568 --> 00:03:57,006 and it's also the year where Danny got married, 99 00:03:57,006 --> 00:04:00,063 where we have, for the first time, the approval by the FDA 100 00:04:00,063 --> 00:04:03,800 of a drug that precisely targets the defect in cystic fibrosis 101 00:04:03,800 --> 00:04:05,738 based upon all this molecular understanding. 102 00:04:05,738 --> 00:04:07,162 That's the good news. 103 00:04:07,162 --> 00:04:10,791 The bad news is, this drug doesn't actually treat all cases of cystic fibrosis, 104 00:04:10,791 --> 00:04:13,000 and it won't work for Danny, and we're still waiting 105 00:04:13,000 --> 00:04:15,335 for that next generation to help him. 106 00:04:15,335 --> 00:04:18,530 But it took 23 years to get this far. That's too long. 107 00:04:18,530 --> 00:04:20,223 How do we go faster? 108 00:04:20,223 --> 00:04:22,921 Well, one way to go faster is to take advantage of technology, 109 00:04:22,921 --> 00:04:25,585 and a very important technology that we depend on 110 00:04:25,585 --> 00:04:27,881 for all of this is the human genome, 111 00:04:27,881 --> 00:04:30,469 the ability to be able to look at a chromosome, 112 00:04:30,469 --> 00:04:33,139 to unzip it, to pull out all the DNA, 113 00:04:33,139 --> 00:04:36,089 and to be able to then read out the letters in that DNA code, 114 00:04:36,089 --> 00:04:38,170 the A's, C's, G's and T's 115 00:04:38,170 --> 00:04:41,441 that are our instruction book and the instruction book for all living things, 116 00:04:41,441 --> 00:04:42,955 and the cost of doing this, 117 00:04:42,955 --> 00:04:45,610 which used to be in the hundreds of millions of dollars, 118 00:04:45,610 --> 00:04:47,523 has in the course of the last 10 years 119 00:04:47,523 --> 00:04:49,922 fallen faster than Moore's Law, down to the point 120 00:04:49,922 --> 00:04:53,929 where it is less than 10,000 dollars today to have your genome sequenced, or mine, 121 00:04:53,929 --> 00:04:57,728 and we're headed for the $1,000 genome fairly soon. 122 00:04:57,728 --> 00:04:59,054 Well, that's exciting. 123 00:04:59,054 --> 00:05:02,864 How does that play out in terms of application to a disease? 124 00:05:02,864 --> 00:05:05,144 I want to tell you about another disorder. 125 00:05:05,144 --> 00:05:07,456 This one is a disorder which is quite rare. 126 00:05:07,456 --> 00:05:10,224 It's called Hutchinson-Gilford progeria, 127 00:05:10,224 --> 00:05:13,529 and it is the most dramatic form of premature aging. 128 00:05:13,529 --> 00:05:17,312 Only about one in every four million kids has this disease, 129 00:05:17,312 --> 00:05:20,672 and in a simple way, what happens is, 130 00:05:20,672 --> 00:05:23,373 because of a mutation in a particular gene, 131 00:05:23,373 --> 00:05:26,040 a protein is made that's toxic to the cell 132 00:05:26,040 --> 00:05:28,337 and it causes these individuals to age 133 00:05:28,337 --> 00:05:30,921 at about seven times the normal rate. 134 00:05:30,921 --> 00:05:34,064 Let me show you a video of what that does to the cell. 135 00:05:34,064 --> 00:05:37,199 The normal cell, if you looked at it under the microscope, 136 00:05:37,199 --> 00:05:40,088 would have a nucleus sitting in the middle of the cell, 137 00:05:40,088 --> 00:05:43,967 which is nice and round and smooth in its boundaries 138 00:05:43,967 --> 00:05:45,722 and it looks kind of like that. 139 00:05:45,722 --> 00:05:47,586 A progeria cell, on the other hand, 140 00:05:47,586 --> 00:05:50,688 because of this toxic protein called progerin, 141 00:05:50,688 --> 00:05:52,972 has these lumps and bumps in it. 142 00:05:52,972 --> 00:05:55,987 So what we would like to do after discovering this 143 00:05:55,987 --> 00:05:57,839 back in 2003 144 00:05:57,839 --> 00:06:01,057 is to come up with a way to try to correct that. 145 00:06:01,057 --> 00:06:04,145 Well again, by knowing something about the molecular pathways, 146 00:06:04,145 --> 00:06:06,144 it was possible to pick 147 00:06:06,144 --> 00:06:08,761 one of those many, many compounds that might have been useful 148 00:06:08,761 --> 00:06:10,222 and try it out. 149 00:06:10,222 --> 00:06:12,797 In an experiment done in cell culture 150 00:06:12,797 --> 00:06:14,839 and shown here in a cartoon, 151 00:06:14,839 --> 00:06:17,533 if you take that particular compound 152 00:06:17,533 --> 00:06:20,789 and you add it to that cell that has progeria, 153 00:06:20,789 --> 00:06:23,010 and you watch to see what happened, 154 00:06:23,010 --> 00:06:25,972 in just 72 hours, that cell becomes, 155 00:06:25,972 --> 00:06:28,240 for all purposes that we can determine, 156 00:06:28,240 --> 00:06:30,082 almost like a normal cell. 157 00:06:30,082 --> 00:06:34,423 Well that was exciting, but would it actually work in a real human being? 158 00:06:34,423 --> 00:06:37,808 This has led, in the space of only four years 159 00:06:37,808 --> 00:06:41,309 from the time the gene was discovered to the start of a clinical trial, 160 00:06:41,309 --> 00:06:43,506 to a test of that very compound. 161 00:06:43,506 --> 00:06:45,469 And the kids that you see here 162 00:06:45,469 --> 00:06:48,031 all volunteered to be part of this, 163 00:06:48,031 --> 00:06:49,492 28 of them, 164 00:06:49,492 --> 00:06:52,587 and you can see as soon as the picture comes up 165 00:06:52,587 --> 00:06:55,969 that they are in fact a remarkable group of young people 166 00:06:55,969 --> 00:06:57,388 all afflicted by this disease, 167 00:06:57,388 --> 00:06:59,637 all looking quite similar to each other. 168 00:06:59,637 --> 00:07:01,311 And instead of telling you more about it, 169 00:07:01,311 --> 00:07:05,297 I'm going to invite one of them, Sam Berns from Boston, 170 00:07:05,297 --> 00:07:07,730 who's here this morning, to come up on the stage 171 00:07:07,730 --> 00:07:09,950 and tell us about his experience 172 00:07:09,950 --> 00:07:11,860 as a child affected with progeria. 173 00:07:11,860 --> 00:07:15,918 Sam is 15 years old. His parents, Scott Berns and Leslie Gordon, 174 00:07:15,918 --> 00:07:18,039 both physicians, are here with us this morning as well. 175 00:07:18,039 --> 00:07:20,577 Sam, please have a seat. 176 00:07:20,577 --> 00:07:27,897 (Applause) 177 00:07:27,897 --> 00:07:30,075 So Sam, why don't you tell these folks 178 00:07:30,075 --> 00:07:33,450 what it's like being affected with this condition called progeria? 179 00:07:33,450 --> 00:07:37,258 Sam Burns: Well, progeria limits me in some ways. 180 00:07:37,258 --> 00:07:41,222 I cannot play sports or do physical activities, 181 00:07:41,222 --> 00:07:44,426 but I have been able to take interest in things 182 00:07:44,426 --> 00:07:47,405 that progeria, luckily, does not limit. 183 00:07:47,405 --> 00:07:49,962 But when there is something that I really do want to do 184 00:07:49,962 --> 00:07:52,979 that progeria gets in the way of, like marching band 185 00:07:52,979 --> 00:07:56,405 or umpiring, we always find a way to do it, 186 00:07:56,405 --> 00:07:59,922 and that just shows that progeria isn't in control of my life. 187 00:07:59,922 --> 00:08:01,632 (Applause) 188 00:08:01,632 --> 00:08:03,668 Francis Collins: So what would you like to say to researchers 189 00:08:03,668 --> 00:08:06,765 here in the auditorium and others listening to this? 190 00:08:06,765 --> 00:08:09,362 What would you say to them both about research on progeria 191 00:08:09,362 --> 00:08:11,248 and maybe about other conditions as well? 192 00:08:11,248 --> 00:08:14,394 SB: Well, research on progeria has come so far 193 00:08:14,394 --> 00:08:16,636 in less than 15 years, 194 00:08:16,636 --> 00:08:21,005 and that just shows the drive that researchers can have 195 00:08:21,005 --> 00:08:24,423 to get this far, and it really means a lot 196 00:08:24,423 --> 00:08:27,674 to myself and other kids with progeria, 197 00:08:27,674 --> 00:08:30,498 and it shows that if that drive exists, 198 00:08:30,498 --> 00:08:33,099 anybody can cure any disease, 199 00:08:33,099 --> 00:08:37,046 and hopefully progeria can be cured in the near future, 200 00:08:37,046 --> 00:08:40,803 and so we can eliminate those 4,000 diseases 201 00:08:40,803 --> 00:08:43,810 that Francis was talking about. 202 00:08:43,810 --> 00:08:46,939 FC: Excellent. So Sam took the day off from school today 203 00:08:46,939 --> 00:08:52,074 to be here, and he is — (Applause) -- 204 00:08:52,074 --> 00:08:56,890 He is, by the way, a straight-A+ student in the ninth grade 205 00:08:56,890 --> 00:08:58,223 in his school in Boston. 206 00:08:58,223 --> 00:09:00,424 Please join me in thanking and welcoming Sam. 207 00:09:00,424 --> 00:09:04,077 SB: Thank you very much. FC: Well done. Well done, buddy. 208 00:09:04,077 --> 00:09:15,895 (Applause) 209 00:09:16,886 --> 00:09:18,602 So I just want to say a couple more things 210 00:09:18,602 --> 00:09:21,734 about that particular story, and then try to generalize 211 00:09:21,734 --> 00:09:24,230 how could we have stories of success 212 00:09:24,230 --> 00:09:27,743 all over the place for these diseases, as Sam says, 213 00:09:27,743 --> 00:09:30,262 these 4,000 that are waiting for answers. 214 00:09:30,262 --> 00:09:32,134 You might have noticed that the drug 215 00:09:32,134 --> 00:09:34,903 that is now in clinical trial for progeria 216 00:09:34,903 --> 00:09:36,667 is not a drug that was designed for that. 217 00:09:36,667 --> 00:09:39,529 It's such a rare disease, it would be hard for a company 218 00:09:39,529 --> 00:09:43,259 to justify spending hundreds of millions of dollars to generate a drug. 219 00:09:43,259 --> 00:09:45,419 This is a drug that was developed for cancer. 220 00:09:45,419 --> 00:09:47,584 Turned out, it didn't work very well for cancer, 221 00:09:47,584 --> 00:09:49,907 but it has exactly the right properties, the right shape, 222 00:09:49,907 --> 00:09:52,799 to work for progeria, and that's what's happened. 223 00:09:52,799 --> 00:09:56,027 Wouldn't it be great if we could do that more systematically? 224 00:09:56,027 --> 00:09:59,823 Could we, in fact, encourage all the companies that are out there 225 00:09:59,823 --> 00:10:01,661 that have drugs in their freezers 226 00:10:01,661 --> 00:10:03,863 that are known to be safe in humans 227 00:10:03,863 --> 00:10:06,155 but have never actually succeeded in terms 228 00:10:06,155 --> 00:10:09,011 of being effective for the treatments they were tried for? 229 00:10:09,011 --> 00:10:11,395 Now we're learning about all these new molecular pathways -- 230 00:10:11,395 --> 00:10:14,474 some of those could be repositioned or repurposed, 231 00:10:14,474 --> 00:10:16,873 or whatever word you want to use, for new applications, 232 00:10:16,873 --> 00:10:19,842 basically teaching old drugs new tricks. 233 00:10:19,842 --> 00:10:22,529 That could be a phenomenal, valuable activity. 234 00:10:22,529 --> 00:10:25,575 We have many discussions now between NIH and companies 235 00:10:25,575 --> 00:10:27,699 about doing this that are looking very promising. 236 00:10:27,699 --> 00:10:30,313 And you could expect quite a lot to come from this. 237 00:10:30,313 --> 00:10:33,352 There are quite a number of success stories one can point to 238 00:10:33,352 --> 00:10:35,705 about how this has led to major advances. 239 00:10:35,705 --> 00:10:37,912 The first drug for HIV/AIDS 240 00:10:37,912 --> 00:10:39,641 was not developed for HIV/AIDS. 241 00:10:39,641 --> 00:10:42,159 It was developed for cancer. It was AZT. 242 00:10:42,159 --> 00:10:44,160 It didn't work very well for cancer, but became 243 00:10:44,160 --> 00:10:46,276 the first successful antiretroviral, 244 00:10:46,276 --> 00:10:48,848 and you can see from the table there are others as well. 245 00:10:48,848 --> 00:10:52,492 So how do we actually make that a more generalizable effort? 246 00:10:52,492 --> 00:10:54,716 Well, we have to come up with a partnership 247 00:10:54,716 --> 00:10:57,576 between academia, government, the private sector, 248 00:10:57,576 --> 00:11:00,029 and patient organizations to make that so. 249 00:11:00,029 --> 00:11:01,679 At NIH, we have started this new 250 00:11:01,679 --> 00:11:04,879 National Center for Advancing Translational Sciences. 251 00:11:04,879 --> 00:11:08,494 It just started last December, and this is one of its goals. 252 00:11:08,494 --> 00:11:09,935 Let me tell you another thing we could do. 253 00:11:09,935 --> 00:11:12,854 Wouldn't it be nice to be able to a test a drug 254 00:11:12,854 --> 00:11:15,225 to see if it's effective and safe 255 00:11:15,225 --> 00:11:17,326 without having to put patients at risk, 256 00:11:17,326 --> 00:11:19,879 because that first time you're never quite sure? 257 00:11:19,879 --> 00:11:22,030 How do we know, for instance, whether drugs are safe 258 00:11:22,030 --> 00:11:25,275 before we give them to people? We test them on animals. 259 00:11:25,275 --> 00:11:27,917 And it's not all that reliable, and it's costly, 260 00:11:27,917 --> 00:11:29,607 and it's time-consuming. 261 00:11:29,607 --> 00:11:32,470 Suppose we could do this instead on human cells. 262 00:11:32,470 --> 00:11:34,702 You probably know, if you've been paying attention 263 00:11:34,702 --> 00:11:36,002 to some of the science literature 264 00:11:36,002 --> 00:11:37,658 that you can now take a skin cell 265 00:11:37,658 --> 00:11:40,539 and encourage it to become a liver cell 266 00:11:40,539 --> 00:11:43,614 or a heart cell or a kidney cell or a brain cell for any of us. 267 00:11:43,614 --> 00:11:46,766 So what if you used those cells as your test 268 00:11:46,766 --> 00:11:49,711 for whether a drug is going to work and whether it's going to be safe? 269 00:11:49,711 --> 00:11:53,942 Here you see a picture of a lung on a chip. 270 00:11:53,942 --> 00:11:57,463 This is something created by the Wyss Institute in Boston, 271 00:11:57,463 --> 00:12:00,638 and what they have done here, if we can run the little video, 272 00:12:00,638 --> 00:12:02,774 is to take cells from an individual, 273 00:12:02,774 --> 00:12:05,883 turn them into the kinds of cells that are present in the lung, 274 00:12:05,883 --> 00:12:07,688 and determine what would happen 275 00:12:07,688 --> 00:12:10,765 if you added to this various drug compounds 276 00:12:10,765 --> 00:12:13,230 to see if they are toxic or safe. 277 00:12:13,230 --> 00:12:15,501 You can see this chip even breathes. 278 00:12:15,501 --> 00:12:18,118 It has an air channel. It has a blood channel. 279 00:12:18,118 --> 00:12:19,821 And it has cells in between 280 00:12:19,821 --> 00:12:22,259 that allow you to see what happens when you add a compound. 281 00:12:22,259 --> 00:12:24,031 Are those cells happy or not? 282 00:12:24,031 --> 00:12:27,062 You can do this same kind of chip technology 283 00:12:27,062 --> 00:12:29,271 for kidneys, for hearts, for muscles, 284 00:12:29,271 --> 00:12:31,735 all the places where you want to see whether a drug 285 00:12:31,735 --> 00:12:34,016 is going to be a problem, for the liver. 286 00:12:34,016 --> 00:12:37,064 And ultimately, because you can do this for the individual, 287 00:12:37,064 --> 00:12:39,278 we could even see this moving to the point 288 00:12:39,278 --> 00:12:42,719 where the ability to develop and test medicines 289 00:12:42,719 --> 00:12:45,905 will be you on a chip, what we're trying to say here is 290 00:12:45,905 --> 00:12:49,406 the individualizing of the process of developing drugs 291 00:12:49,406 --> 00:12:51,654 and testing their safety. 292 00:12:51,654 --> 00:12:53,306 So let me sum up. 293 00:12:53,306 --> 00:12:55,566 We are in a remarkable moment here. 294 00:12:55,566 --> 00:12:57,669 For me, at NIH now for almost 20 years, 295 00:12:57,669 --> 00:13:00,270 there has never been a time where there was more excitement 296 00:13:00,270 --> 00:13:02,855 about the potential that lies in front of us. 297 00:13:02,855 --> 00:13:04,647 We have made all these discoveries 298 00:13:04,647 --> 00:13:07,012 pouring out of laboratories across the world. 299 00:13:07,012 --> 00:13:10,374 What do we need to capitalize on this? First of all, we need resources. 300 00:13:10,374 --> 00:13:13,929 This is research that's high-risk, sometimes high-cost. 301 00:13:13,929 --> 00:13:15,900 The payoff is enormous, both in terms of health 302 00:13:15,900 --> 00:13:18,780 and in terms of economic growth. We need to support that. 303 00:13:18,780 --> 00:13:21,081 Second, we need new kinds of partnerships 304 00:13:21,081 --> 00:13:23,302 between academia and government and the private sector 305 00:13:23,302 --> 00:13:26,649 and patient organizations, just like the one I've been describing here, 306 00:13:26,649 --> 00:13:30,229 in terms of the way in which we could go after repurposing new compounds. 307 00:13:30,229 --> 00:13:33,465 And third, and maybe most important, we need talent. 308 00:13:33,465 --> 00:13:35,606 We need the best and the brightest 309 00:13:35,606 --> 00:13:38,463 from many different disciplines to come and join this effort -- 310 00:13:38,463 --> 00:13:40,909 all ages, all different groups -- 311 00:13:40,909 --> 00:13:42,996 because this is the time, folks. 312 00:13:42,996 --> 00:13:46,621 This is the 21st-century biology that you've been waiting for, 313 00:13:46,621 --> 00:13:49,083 and we have the chance to take that 314 00:13:49,083 --> 00:13:51,573 and turn it into something which will, in fact, 315 00:13:51,573 --> 00:13:53,903 knock out disease. That's my goal. 316 00:13:53,903 --> 00:13:55,787 I hope that's your goal. 317 00:13:55,787 --> 00:13:58,467 I think it'll be the goal of the poets and the muppets 318 00:13:58,467 --> 00:14:00,476 and the surfers and the bankers 319 00:14:00,476 --> 00:14:02,754 and all the other people who join this stage 320 00:14:02,754 --> 00:14:04,504 and think about what we're trying to do here 321 00:14:04,504 --> 00:14:05,669 and why it matters. 322 00:14:05,669 --> 00:14:08,439 It matters for now. It matters as soon as possible. 323 00:14:08,439 --> 00:14:11,557 If you don't believe me, just ask Sam. 324 00:14:11,557 --> 00:14:13,000 Thank you all very much. 325 00:14:13,000 --> 00:14:17,831 (Applause)